Citadel Advisors’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-17,600
| Closed | -$1.13M | – | 10366 |
|
|
2018
Q3 | $1.13M | Buy |
17,600
+9,700
| +123% | +$591K | ﹤0.01% | 5323 |
|
|
2018
Q2 | $386K | Sell |
7,900
-3,200
| -29% | -$166K | ﹤0.01% | 6795 |
|
|
2018
Q1 | $522K | Sell |
11,100
-3,700
| -25% | -$178K | ﹤0.01% | 5812 |
|
|
2017
Q4 | $737K | Buy |
14,800
+6,200
| +72% | +$308K | ﹤0.01% | 5091 |
|
|
2017
Q3 | $498K | Buy |
+8,600
| New | +$511K | ﹤0.01% | 5335 |
|
|
2016
Q3 | – | Sell |
-3,100
| Closed | -$203K | – | 8350 |
|
|
2016
Q2 | $203K | Sell |
3,100
-700
| -18% | -$47.6K | ﹤0.01% | 5814 |
|
|
2016
Q1 | $263K | Buy |
3,800
+2,600
| +217% | +$174K | ﹤0.01% | 5275 |
|
|
2015
Q4 | $88K | Sell |
1,200
-1,500
| -56% | -$107K | ﹤0.01% | 6835 |
|
|
2015
Q3 | $191K | Sell |
2,700
-1,200
| -31% | -$97.4K | ﹤0.01% | 6216 |
|
|
2015
Q2 | $339K | Buy |
3,900
+1,900
| +95% | +$144K | ﹤0.01% | 5582 |
|
|
2015
Q1 | $147K | Buy |
2,000
+1,300
| +186% | +$92.2K | ﹤0.01% | 6517 |
|
|
2014
Q4 | $50K | Sell |
700
-11,100
| -94% | -$769K | ﹤0.01% | 7210 |
|
|
2014
Q3 | $816K | Buy |
11,800
+6,700
| +131% | +$471K | ﹤0.01% | 3970 |
|
|
2014
Q2 | $317K | Sell |
5,100
-3,300
| -39% | -$194K | ﹤0.01% | 5012 |
|
|
2014
Q1 | $458K | Buy |
8,400
+3,700
| +79% | +$198K | ﹤0.01% | 4464 |
|
|
2013
Q4 | $248K | Buy |
4,700
+1,400
| +42% | +$70.3K | ﹤0.01% | 4802 |
|
|
2013
Q3 | $154K | Sell |
3,300
-800
| -20% | -$38.3K | ﹤0.01% | 5002 |
|
|
2013
Q2 | $200K | Buy |
+4,100
| New | +$197K | ﹤0.01% | 4674 |
|
Other funds holding LPNT
Citadel Advisors's LPNT Position: Q4 2018 in Review
Citadel Advisors sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 9,823 shares — an estimated $633K sold.
Citadel Advisors first reported a position in LPNT in Q2 2013 and held it in 21 quarters. The position peaked at $42.4M in Q2 2016. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- Citadel Advisors reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- Citadel Advisors sold 9,823 LifePoint Health, Inc. shares in Q4 2018, an estimated $633K.
- Citadel Advisors first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 21 quarters.
- Citadel Advisors's LifePoint Health, Inc. position peaked at $42.4M in Q2 2016.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.